| Bioactivity | Suvodirsen sodium induces exon 51 skipping and has the potential for study Duchenne muscular dystrophy (DMD)[1]. |
| Name | Suvodirsen sodium |
| CAS | 2142024-01-7 |
| Formula | C196H211F15N76Na19O108P19S15 |
| Molar Mass | 7150.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. K. Wagner, et al. O.28Safety and tolerability of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy: results from a phase 1 clinical trial. 2019. |
Suvodirsen sodium
CAS: 2142024-01-7 F: C196H211F15N76Na19O108P19S15 W: 7150.47
Suvodirsen sodium induces exon 51 skipping and has the potential for study Duchenne muscular dystrophy (DMD).
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.